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Abstract
A serious complication to the laparoscopic Roux-en-Y gastric bypass (RYGB)
is internal hernia, which can lead to massive bowel necrosis that may result in
short bowel syndrome. We determined postprandial enteropancreatic hor-
monal responses and metabolites in a 22-year-old nondiabetic woman with a
history of RYGB experiencing severe internal herniation with widespread
bowel necrosis. Extensive resections were performed leaving her with a saliva
fistula from the pouch-enteric anastomosis, an intact duodenum, 15 cm of
jejunum, 35 cm of ileum, and intact colon. Parenteral nutrition was initiated
and 10 months after the bowel resection, intestinal continuity was re-estab-
lished. After 6 weeks the patient reached parenteral nutrition independence.
She underwent standardized liquid mixed meal tests before, 3 months after
and 2 years after intestinal continuity was re-established. Gut hormone
responses were completely restored postoperatively leading to very high con-
centrations in plasma. After 2 years, plasma concentrations had, however,
decreased markedly, suggesting desensitization of the gut ostensibly in
response to chronic hyperstimulation. There was no evidence of cephalic
phase insulin secretion.
Introduction
The gastrointestinal architecture after Roux-en-Y gastric
bypass (RYGB) surgery elicits increases in the exposure of
distal parts of the small intestine to nutrients while the
enteroendocrine cells in the duodenum are excluded from
the nutrient flow. Enteroendocrine L cells in the distal
parts of the small intestine respond with increased secre-
tion of glucagon-like peptide-1 (GLP-1), glucagon-like
peptide-2 (GLP-2) and peptide YY (PYY). GLP-1 and
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glucose-dependent insulinotropic polypeptide (GIP),
which are secreted from K cells in the upper small intes-
tine, stimulate the secretion of insulin (incretin effect)
(Holst 2013). Moreover, GLP-1 and PYY, together with
cholecystokinin (CCK) from the upper intestine, inhibit
appetite, gastric emptying and food intake. GLP-1 in
addition suppresses glucagon secretion, which together
with GLP-1-induced deceleration of gastric emptying and
GLP-1-induced insulin secretion is crucial for the regula-
tion of postprandial glucose homeostasis. GLP-2 exerts
trophic effects on the intestinal mucosa (Drucker 2001).
GLP-2 also enhances the absorption of nutrients and gut
adaptation in patients with various resections. RYGB
results in favorable effects on glucose and energy home-
ostasis, but can also be associated with severe complica-
tions resulting in intestinal failure, hypoglycemia, and
short bowel syndrome (Borghede et al. 2013).
We determined metabolites and postprandial gas-
trointestinal and pancreatic hormone concentrations in
plasma and serum from a 22-year-old nondiabetic
woman who had experienced severe internal herniation
after RYGB and subsequent extensive bowel resection
resulting in short bowel syndrome (Fig. 1) (Borghede
et al. 2013).
Materials and Methods
The patient received a standardized (800 kcal) liquid
test meal (90 g carbohydrate, 31 g fat, 40 g protein)
7 days before, 3 months after and 2 years after restora-
tion of gastrointestinal continuity. Three resections had
left the patient with a saliva fistula 10 cm below the
pouch-enteric anastomosis, a jejunostomy 15 cm from
the ligament of Treitz and a blind closed ileum 35 cm
from the ileo-coecal valve. 10 months after the intesti-
nal continuity was reestablished (Fig. 1) (Borghede et al.
2013). The patient had her gallbladder removed prior
to herniation, but was otherwise healthy. Prior to surgi-
cal reestablishment of intestinal continuity, she received
parenteral nutrition 4 days a week, which was discon-
tinued 6 weeks after surgery. Paracetamol was added to
the last liquid meal for evaluation of gastric emptying.
Each meal test was performed after an overnight fast
(10 h). The patient was positioned in a 45° recumbent
position and had a cannula inserted in the cubital vein.
Blood was arterialized by wrapping the lower arm and
hand in a heating pad. Blood samples were drawn
repeatedly and distributed into chilled EDTA tubes
prepared with Trasylol (Nordic Drugs, aprotinin,
Figure 1. The intestinal system of a 22-year-old woman, with a history of Roux-en-Y gastric bypass, complicated with internal hernia and
massive bowel necrosis. After extensive bowel resection the patient ended up with a saliva fistula from the pouch-enteric anastomosis, a
jejunostomy 15 cm from the ligament of Treitz, and a blind closed ileum 35 cm from the ileo-coecal valve (left). Ten months later the intestinal
continuity was re-established (right).
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500KIU/mL) for plasma analysis of gastrointestinal
hormones and metabolites. For measurements of insulin
and C-peptide, blood was distributed into chilled tubes
containing heparin. Tubes were kept on ice until cen-
trifugation (20 min at 1200 g, 4°C). Plasma for the
analysis of glucagon, GIP, GLP-1, GLP-2, polypeptide
(PYY), CCK, gastrin, pancreatic polypeptide (PP), and
somatostatin was stored at 20°C and plasma samples
for insulin and C-peptide were stored at 80°C. For
the analyses of paracetamol and bile acids blood was
distributed into dry tubes for coagulation (20 min at
room temperature). For the analyses of plasma glucose,
blood was collected in sodium-fluoride-coated tubes
and centrifuged immediately at 7400 g for 2 min at
room temperature. Glucose concentrations were mea-
sured bedside by the glucose oxidase method (Yellow
Springs Instrument model 2300 STAT plus analyzer;
YSI, Yellow Springs, OH, USA). Plasma insulin, C-pep-
tide and triglyceride concentrations were measured
using a two-sided electrocheminescence immunoassay
(Roche/Hitachi Modular analytics; Roche Diagnostics,
Mannheim, Germany). Gastrointestinal hormones were
measured by radioimmunoassays as described elsewhere
(Sonne et al. 2014). Serum paracetamol was measured
by the Vitros ACET slide (Sonne et al. 2014). Total
serum bile acids were measured using the enzymatic
colorimetric method (Konelab 30i, Thermo Fisher
Scientific, Hvidovre, Denmark).
Results
Weight
The patients’ weight was 54 kg before the operation,
57 kg at 3 months and 76 kg after 2 years. The corre-
sponding body mass indices were 19.7 kg/m2, 20.7 kg/m2,
and 27.6 kg/m2, respectively.
Glucose, insulin, C-peptide and glucagon
Before surgery, plasma concentrations of glucose, insulin,
C-peptide and glucagon remained at baseline throughout
the meal test (Fig. 2). Three months after reconstructive
surgery, postprandial glucose, insulin and C-peptide con-
centrations exhibited bi-phasic profiles with peaks at
30 min and 150 min. After 2 years, postprandial glucose,
insulin and C-peptide concentrations were markedly
increased. Peak concentrations of both glucose, insulin
and C-peptide appeared early (~45 min) with C-peptide
plateauing at 1500–1700 pmol/L, whereas insulin concen-
trations decreased after peaking at 370 pmol/L. Glucose
concentrations plateaued at 5.5–6.2 mmol/L after
~30 min. Baseline concentrations of glucagon were low
(1–2 pmol/L) before and after surgery. After surgery,
postprandial concentrations increased slowly and peaked
after 180 min (7–8 pmol/L), with slightly higher concen-
trations at 3 months compared to 2 years postoperatively.
GIP, GLP-1, GLP-2, and PYY
Three months postoperatively, GIP increased markedly
between 30 and 120 min reaching peak concentrations at
~50 pmol/L (Fig. 2). After 2 years, GIP concentrations
peaked at 45 min (~30 pmol/L) and remained somewhat
constant throughout the test. Two months postopera-
tively, GLP-1 and GLP-2 concentrations reached
50 pmol/L and 100 pmol/L, respectively, and both hor-
mones exhibited high peak concentrations (~150 pmol/L)
at 150 min. At the two-year follow-up, no late peaks were
seen and all three hormones remained at their respective
plateaus (GIP ~50 pmol/L, GLP-1 ~50 pmol/L, GLP-2
~60-70 pmol/L). Similarly, PYY concentrations increased
progressively reaching 1400 pg/mL at 150 min 3 months
postoperatively. After 2 years, PYY concentrations reached
~500 pg/mL after 45 min and remained here throughout
the meal test.
CCK, gastrin, somatostatin, and total bile
acids
CCK concentrations exhibited three peaks (8-10 pmol/L)
at the three-month follow-up (Fig. 2). The last and largest
peak was seen at 150 min (~10.5 pmol/L). After 2 years,
this pattern remained, but at lower concentrations. Gas-
trin concentrations increased throughout the meal tests
reaching peak concentrations of 27 pmol/L (3 months)
and 47 pmol/L (2 years), respectively. Somatostatin con-
centrations remained constant at 15–20 pmol/L before
the operation. After reconstructive surgery, basal concen-
trations decreased to ~6 pmol/L and exhibited postpran-
dial suppression at 60 min. Total bile acid concentrations
after 3 months reached 10–12 lmol/L and returned to
baseline after 3–4 h. However, 2 years after surgery, bile
acid concentrations increased throughout the meal test
reaching 44 lmol/L at 240 min.
PP, triglyceride and paracetamol
PP remained at baseline in the preoperative setting
(Fig. 2). Three months after reconstructive surgery
three large PP peaks (~140–180 pmol/L) were observed
at 30, 75, and 150 min, respectively. After 2 years,
however, only a minor increase in PP was observed at
~15 min and again at ~180 min. Triglyceride concen-
trations showed no postprandial changes before or after
surgery, but concentrations increased from 0.5 mmol/L
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before surgery to ~1 mmol/L after reconstruction.
Paracetamol concentrations (a surrogate marker of gas-
tric emptying) increased throughout the meal test indi-
cating gradual, regulated emptying of the gastric
contents of the meal.
Discussion
We present enteroendocrine and pancreatic endocrine
responses in a young woman with severe complications
after RYGB resulting in short bowel syndrome. A key
finding of the study is the demonstration of the ability of
the gut to adapt and restore both its pancreatic and endo-
crine function after having remained dormant for more
than 10 months. Meal tests were carried out before and
after restoration of intestinal continuity. Postprandial
plasma concentrations of the gastrointestinal and pancreatic
hormones were unaffected by food intake prior to the
re-establishment of intestinal continuity, but were restored
after re-establishment of intestinal continuity. Because of the
unique anatomy prior to reconstructive surgery, the meal
may be considered a true sham feeding.
Glucose regulation, L cell products, and
gastric emptying
Glucose as well as insulin/C-peptide concentrations
increased during the 2 years. These changes may represent
the return of an insulin resistant state because of the
patient0s weight gain. Two years after reconstructive sur-
gery, postprandial concentrations of GLP-1, GLP-2, PYY,
and GIP were blunted compared to the marked release
observed at 3 months. This suggests that the gut becomes
desensitized when hyperstimulated over time. A similar
Figure 2. Postprandial plasma/serum concentrations of glucose, insulin, C-peptide, glucagon, glucose-dependent insulinotropic polypeptide
(GIP), glucagon-like peptide-1 (GLP-1), glucagon-like peptide-2 (GLP-2), peptide YY (PYY), gastrin, cholecystokinin (CCK), somatostatin,
pancreatic polypeptide (PP), total bile acids (TBA), triglycerides and paracetamol before (solid circles), 3 months after (open circles) and 2 years
after (solid triangles) intestinal continuity was re-established.
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‘adaptive pattern’ was also observed for CCK and gastrin.
However, based on paracetamol absorption and GIP con-
centrations (known to reflect the gastric emptying), an
element of gastric retention also seems evident. Indeed,
even gastrin, which is secreted from the antrum of the
stomach, continued to increase during the postoperative
meal tests. Clinically, however, the patient has never
presented symptoms of gastric retention. Neither did
imaging of the stomach and intestine with contrast show
any signs of retention or stenosis at the level of the anas-
tomoses.
The early postprandial increase of GLP-1, GIP, and
GLP-2 concentrations were comparable to those observed
after RYGB surgery (Jacobsen et al. 2012; Jørgensen et al.
2012), but our patient also exhibited a high peak after
150 min, indicating a possible stimulation of colonic L
cells. Normally, this peak is not observed during mixed
meal tests performed in healthy subjects or in RYGB
patients (Jacobsen et al. 2012; Jørgensen et al. 2012). Nei-
ther did it appear during the meal test at two-year fol-
low-up. Likewise, PYY, a satiety hormone at least partially
co-secreted with GLP-1, reached a peak concentration of
1400 pg/mL (~330 pmol/L) at 150 min - a considerably
higher peak than normally observed following RYGB sur-
gery (Korner et al. 2005). GLP-2 exerts trophic effects on
the intestine, enhancing absorption of nutrients and pro-
moting intestinal growth, which is beneficial for patients
with short bowel syndrome (Drucker 2001). Indeed,
6 weeks after the intestinal continuity was re-established
our patient was able to manage without parenteral nutri-
tion (Borghede et al. 2013). The re-established intestinal
continuity and an intact colon are important for the
restoration of L cell secretion, and our data therefore sug-
gest that the colon may substitute for the small intestine
with regards to the secretion of these hormones. Indeed,
enhanced L cell secretion might facilitate increased
absorption capacity of the small intestine and even pro-
mote intestinal growth (Jeppesen et al. 2012; Hvistendahl
et al. 2016). Basal glucagon concentrations were low and
postprandial concentrations increased progressively during
both postsurgery meal tests. Hyperglucagonemia was not
present and glucagon concentrations stayed below
10 pmol/L.
Cephalic insulin secretion and PP
Because of the anatomical situation before surgery, the
meal test represents sham feeding. However, PP concen-
trations before reconstruction were unaffected by meal
intake, which suggests lack of vagal signaling (probably as
a consequence of the operations). PP, however, increased
postoperatively probably reflecting intestinal stimulation.
Accordingly, there was no sign of cephalic phase insulin
secretion, which is thought to take place during the first
10 minutes following meal intake (Teff et al. 1991; Ahren
and Holst 2001), although findings in humans are incon-
sistent as some studies do not find cephalic phase insulin
secretion (Crystal and Teff 2006; Veedfald et al. 2016). A
cephalic insulin response could also have gone unnoticed
due to the study design, in which a 15-min sampling
interval was applied.
Gastrin, CCK, somatostatin, bile acids, and
triglycerides
Postprandial plasma concentrations of CCK were compa-
rable to those normally seen after RYGB and a clear
reduction was observed 2 years after surgery (Jacobsen
et al. 2012). Three CCK peaks were observed which could
represent variable CCK processing or secretion through-
out the intestine. Gastrin concentrations increased during
the entire meal test, which could indicate a gradual emp-
tying of the gastric contents postoperatively – as also sug-
gested by the paracetamol/GIP data. We observed
reduced somatostatin (measured in a way to include both
the 1–14 and the 1–28 forms) secretion after the opera-
tion, which is surprising since some of the somatostatin
cells in the intestinal mucosa are of the open type and
would be expected to respond to luminal stimulation.
Together with the finding of suppressed postprandial
somatostatin concentrations, these results could indicate
that stimulation of the gut per se impacts negatively on
somatostatin release. Total bile acid concentrations
increased massively at the two-year follow-up confirming
previous findings of high bile acid concentrations years
after RYGB surgery (Jørgensen et al. 2015). Most likely,
gut adaptation or remodeling resulting in increased trans-
port of both conjugated and unconjugated bile acids is a
likely explanation. Triglycerides were unaffected by this
increase in bile acid transport and postoperative plasma
concentrations did not indicate improved absorption over
time.
In conclusion, our patient experienced severe internal
herniation after RYGB surgery and underwent extensive
bowel resections resulting in short bowel syndrome and
disappearance of normal postprandial enteroendocrine
and pancreatic endocrine responses. The meal test per-
formed prior to reconstructive surgery was interpreted as
a human sham-feeding test, but no cephalic phase release
of insulin was demonstrated. Three months after recon-
structive surgery postprandial gut hormone concentra-
tions were fully restored and maintained for 2 years,
albeit at lower concentrations with time. Glucose, insulin/
C-peptide and weight, however, increased postoperatively
and total bile acid concentrations were also markedly
increased 2 years after surgery.
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